| John Pandolfino, MD | |
|
680 N Lake Shore Dr, Suite 1000, Chicago, IL 60611-4546 | |
| (312) 695-9797 | |
| Not Available |
| Full Name | John Pandolfino |
|---|---|
| Gender | Male |
| Speciality | Gastroenterology |
| Experience | 31 Years |
| Location | 680 N Lake Shore Dr, Chicago, Illinois |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1396770277 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207RG0100X | Internal Medicine - Gastroenterology | (Illinois) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Northwestern Memorial Hospital | Chicago, IL | Hospital |
| Palos Community Hospital | Palos heights, IL | Hospital |
| Northwestern Medicine Mchenry Hospital | Mchenry, IL | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Northwestern Medical Faculty Foundation | 4587576814 | 3255 |
News Archive
Scientists from the Gladstone Institutes have identified a new pathway by which salicylic acid-a key compound in the nonsteroidal anti-inflammatory drugs aspirin and diflunisal-stops inflammation and cancer.
Omega Healthcare Investors, Inc. today announced its results of operations for the three-month period ended March 31, 2011.
U-Systems announced today that Radiology Regional Center has initiated participation in the SOMO•INSIGHT Clinical Study. The first breast center in Southwest Florida to participate, Radiology Regional Center is recruiting participants for the national clinical research study designed to evaluate whether digital mammography in combination with the somo•v™ Automated Breast Ultrasound System (ABUS) from U-Systems is more sensitive to detecting breast lesions when compared to Mammography alone in women with dense breasts.
Affinion Security Center, a leading provider of identity theft protection services, today announced enhancements to its BreachShield(SM) service, aimed at preventing, detecting and resolving Identity Theft resulting from data breaches for companies at risk and the consumers who trust those organizations. The new enhancements are designed for all types of organizations that experience a breach and include benefits that help customers at risk for medical identity theft.
Celgene Cellular Therapeutics, a wholly owned subsidiary of Celgene Corporation, today announced initial results from a Phase I multicenter safety study of PDA-001 in treatment-resistant Crohn's Disease. PDA-001 is an immunomodulatory therapy consisting of human placenta-derived cells obtained from CCT's proprietary processes.
› Verified 8 days ago
| Entity Name | Northwestern Medical Faculty Foundation |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1346235314 PECOS PAC ID: 4587576814 Enrollment ID: O20031105000541 |
News Archive
Scientists from the Gladstone Institutes have identified a new pathway by which salicylic acid-a key compound in the nonsteroidal anti-inflammatory drugs aspirin and diflunisal-stops inflammation and cancer.
Omega Healthcare Investors, Inc. today announced its results of operations for the three-month period ended March 31, 2011.
U-Systems announced today that Radiology Regional Center has initiated participation in the SOMO•INSIGHT Clinical Study. The first breast center in Southwest Florida to participate, Radiology Regional Center is recruiting participants for the national clinical research study designed to evaluate whether digital mammography in combination with the somo•v™ Automated Breast Ultrasound System (ABUS) from U-Systems is more sensitive to detecting breast lesions when compared to Mammography alone in women with dense breasts.
Affinion Security Center, a leading provider of identity theft protection services, today announced enhancements to its BreachShield(SM) service, aimed at preventing, detecting and resolving Identity Theft resulting from data breaches for companies at risk and the consumers who trust those organizations. The new enhancements are designed for all types of organizations that experience a breach and include benefits that help customers at risk for medical identity theft.
Celgene Cellular Therapeutics, a wholly owned subsidiary of Celgene Corporation, today announced initial results from a Phase I multicenter safety study of PDA-001 in treatment-resistant Crohn's Disease. PDA-001 is an immunomodulatory therapy consisting of human placenta-derived cells obtained from CCT's proprietary processes.
› Verified 8 days ago
| Mailing Address | Practice Location Address |
|---|---|
| John Pandolfino, MD 680 N Lake Shore Dr, Suite 1000, Chicago, IL 60611-4546 Ph: (312) 695-9797 | John Pandolfino, MD 680 N Lake Shore Dr, Suite 1000, Chicago, IL 60611-4546 Ph: (312) 695-9797 |
News Archive
Scientists from the Gladstone Institutes have identified a new pathway by which salicylic acid-a key compound in the nonsteroidal anti-inflammatory drugs aspirin and diflunisal-stops inflammation and cancer.
Omega Healthcare Investors, Inc. today announced its results of operations for the three-month period ended March 31, 2011.
U-Systems announced today that Radiology Regional Center has initiated participation in the SOMO•INSIGHT Clinical Study. The first breast center in Southwest Florida to participate, Radiology Regional Center is recruiting participants for the national clinical research study designed to evaluate whether digital mammography in combination with the somo•v™ Automated Breast Ultrasound System (ABUS) from U-Systems is more sensitive to detecting breast lesions when compared to Mammography alone in women with dense breasts.
Affinion Security Center, a leading provider of identity theft protection services, today announced enhancements to its BreachShield(SM) service, aimed at preventing, detecting and resolving Identity Theft resulting from data breaches for companies at risk and the consumers who trust those organizations. The new enhancements are designed for all types of organizations that experience a breach and include benefits that help customers at risk for medical identity theft.
Celgene Cellular Therapeutics, a wholly owned subsidiary of Celgene Corporation, today announced initial results from a Phase I multicenter safety study of PDA-001 in treatment-resistant Crohn's Disease. PDA-001 is an immunomodulatory therapy consisting of human placenta-derived cells obtained from CCT's proprietary processes.
› Verified 8 days ago
Dr. Sorin C Danciu, M.D. Gastroenterology Medicare: Accepting Medicare Assignments Practice Location: 3134 N Clark St, Chicago, IL 60657 Phone: 773-880-9722 | |
Anoopa A. Koshy, MD Gastroenterology Medicare: Accepting Medicare Assignments Practice Location: 259 E Erie St Ste 2200, Chicago, IL 60611 Phone: 312-926-6000 | |
William Edmond Gerardi, M.D. Gastroenterology Medicare: Not Enrolled in Medicare Practice Location: 3730 N Lake Shore Dr, Apartment 2a, Chicago, IL 60613 Phone: 773-244-3060 | |
Suparna Dutta, M.D. Gastroenterology Medicare: Accepting Medicare Assignments Practice Location: 1700 W Van Buren St, Suite 500, Chicago, IL 60612 Phone: 312-942-4200 Fax: 312-942-3568 | |
Alexandra Dumitrescu, Gastroenterology Medicare: Accepting Medicare Assignments Practice Location: 5841 S Maryland Ave, Chicago, IL 60637 Phone: 888-824-0200 | |
Dr. Mitesh Mahesh Kabadi, M.D. Gastroenterology Medicare: Accepting Medicare Assignments Practice Location: 1725 W Harrison St Ste 1159, Chicago, IL 60612 Phone: 312-942-5020 | |
Dr. Marta Batus, MD Gastroenterology Medicare: Accepting Medicare Assignments Practice Location: 1725 W Harrison St, Suite 809, Chicago, IL 60612 Phone: 312-563-2487 Fax: 312-942-3192 |